GPC1 and pachyonychia congenita: Undoubtedly, these findings should be verified with a larger series of the sample, but the striking evidence provided by Melo and colleagues suggest that GPC1+ exosomes may serve as a potential diagnostic and screening biomarker to detect early stages of PC for possible curative surgery.